成功根管治疗降低心血管疾病风险血清生物标志物
本研究对非手术根管再治疗和根尖周手术患者进行2年随访,发现治疗成功者血清hs-CRP、ADMA和MMP-2显著降低,且HbA1C、TC、LDL和HDL也显著改善,提示成功治疗慢性根尖周炎与代谢综合征指标改善及心血管疾病风险标志物降低相关。
要点
- 成功根管再治疗和根尖周手术可降低血清hs-CRP、ADMA和MMP-2水平。
- 治疗成功与代谢综合征指标改善和血糖控制更好相关。
- hs-CRP、ADMA和MMP-2可作为治疗成功的预后生物标志物。
核心结论
- hs-CRP、ADMA和MMP-2可视为成功根管再治疗和根尖周手术的预后生物标志物。
- 成功治疗慢性根尖周炎与代谢综合征指标改善、血糖控制更好及部分全身炎症标志物降低相关。
研究设计与样本
- 对既往研究中的受试者在治疗后2年进行召回随访。
- 2年召回率为56.9%(n=37),根尖周X线片显示100%影像学成功率。
主要发现
- 21例(56.8%)完全愈合,16例(43.2%)愈合中。
- 愈合中组的MMP2水平高于完全愈合组。
- 血清hs-CRP、ADMA和MMP-2水平显著降低(p ≤ .001)。
- HbA1C(p = .015)、TC(p = .003)、LDL(p = .003)和HDL(p = .003)在治疗后2年较术前显著降低。
- COVID感染与MMP-9显著相关(p = .048)。
关键数值与推荐
- 2年召回率56.9%(n=37),影像学成功率100%。
- 完全愈合21例(56.8%),愈合中16例(43.2%)。
- hs-CRP、ADMA和MMP-2降低的p值均≤.001。
- HbA1C降低p = .015,TC、LDL和HDL降低p = .003。
- COVID感染与MMP-9相关p = .048。
临床怎么用
- 可将hs-CRP、ADMA和MMP-2作为根管再治疗和根尖周手术成功的预后生物标志物。
- 对慢性根尖周炎患者应关注代谢综合征指标和血糖控制,成功治疗可能带来全身获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate serum biomarkers of inflammation 2 years following non-surgical root canal re-treatment (Re-RCT) and peri-apical surgery (PS). The results were correlated with signs and symptoms, treatment outcome, metabolic syndrome factors, infection with severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 (COVID-19) infection and COVID-19 vaccination. METHODOLOGY: Subjects from our previous study were recalled for 2 years post-treatment follow-up. Changes to the patient's history (medical, dental, social) were noted. Periapical health of the treated teeth was examined both clinically and radiographically. Blood pressure, fasting HbA1C and low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides and total cholesterol (TC) levels were measured. Serum inflammatory marker levels were assayed using a Bio-Rad Bio-Plex 200 analyser and values at different time points within the same group were compared using a Wilcoxon signed-rank test and differences between groups with a Mann-Whitney test. Linear associations were tested using Pearson's correlations. RESULTS: The recall percentage at 2 years was 56.9% (n = 37), with a 100% radiographic success rate using periapical radiographs. In total, 21 cases (56.8%) were completely healed, and 16 cases (43.2%) were healing. Higher matrix metalloprotease 2 (MMP2) levels were present in the healing group compared to the healed group. Serum levels of high-sensitivity C-reactive protein (hs-CRP), asymmetric dimethylarginine (ADMA) and MMP-2 were significantly reduced (p ≤ .001) whereas other biomarkers showed significant increases at 2 year compared to pre-operative levels, while FGF-23 and ICAM-1 were not significantly increased. HbA1C (p = .015), TC (p = .003), LDL (p = .003) and HDL (p = .003) reduced significantly at 2 years post-treatment compared to their preoperative levels. COVID infection showed a significant association with MMP-9 (p = .048). CONCLUSIONS: hs-CRP, ADMA and MMP-2 can be regarded as prognostic biomarkers of successful Re-RCT and PS as they reduced at 2 year recall in cases which showed evidence of clinical and radiographic success. The successful treatment of chronic apical periodontitis is correlated with improvements in metabolic syndrome indicators, better glycemic control, and reduction at 2 year of some systemic inflammatory markers which are related to risks of cardiovascular disease events.
引用
- Al-Abdulla N, Bakhsh A, Mannocci F, et al. Successful endodontic treatment reduces serum levels of cardiovascular disease risk biomarkers-high-sensitivity C-reactive protein, asymmetric dimethylarginine, and matrix metalloprotease-2. Int Endod J. 2023. PMID: 37787168. doi:10.1111/iej.13979
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。